Published in J Immunol on October 01, 1993
Cytokines in asthma. Thorax (1999) 2.64
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A (1999) 2.14
Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci U S A (1997) 1.39
Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med (1996) 1.27
Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. J Immunol (2005) 1.25
Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc Natl Acad Sci U S A (1997) 1.20
Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J Exp Med (2001) 1.20
The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med (1998) 1.19
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade. Blood (2008) 1.16
Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J Clin Invest (1997) 0.98
Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. PLoS One (2008) 0.98
Apoptosis and inflammation. Mediators Inflamm (1995) 0.96
Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc Natl Acad Sci U S A (1997) 0.93
Temporal changes in chromatin, intracellular calcium, and poly(ADP-ribose) polymerase during Sindbis virus-induced apoptosis of neuroblastoma cells. J Virol (1996) 0.91
Multiple apoptotic defects in hematopoietic cells from mice lacking lipocalin 24p3. J Biol Chem (2011) 0.84
Rat bone marrow-derived mast cells co-cultured with 3T3 fibroblasts in the absence of T-cell derived cytokines require stem cell factor for their survival and maintain their mucosal mast cell-like phenotype. Immunology (1996) 0.84
Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans. Front Immunol (2012) 0.81
Characterization of a mast cell line that lacks the extracellular domain of membrane c-kit. Immunology (1997) 0.81
Involvement of transcription factor encoded by the mouse mi locus (MITF) in apoptosis of cultured mast cells induced by removal of interleukin-3. Am J Pathol (1997) 0.80
Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology (2000) 0.80
Tyrosine phosphorylation participates in peripheral T-cell activation and programmed cell death in vivo. Immunology (1995) 0.78
Induction of apoptosis in a human hepatocellular carcinoma cell line by a neutralizing antibody to transforming growth factor-alpha. Virchows Arch (1997) 0.78
Reduced expression of IL-3 mediates intestinal mast cell depletion in diabetic rats: role of insulin and glucocorticoid hormones. Int J Exp Pathol (2009) 0.76
Nitric oxide induces apoptosis in a human colonic epithelial cell line, T84. Mediators Inflamm (1995) 0.76
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A (1995) 3.85
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58
Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol (1988) 3.57
Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods (1995) 3.54
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med (1987) 2.59
The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy (2007) 2.44
Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood (1999) 2.38
Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A (1991) 2.17
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A (1999) 2.14
Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology (1988) 2.11
A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. J Allergy Clin Immunol (1989) 2.03
Mast cells in innate immunity. Immunol Rev (2000) 1.76
Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol (1992) 1.70
Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol (1991) 1.69
The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest (1995) 1.63
The mast cell. Crit Rev Immunol (1981) 1.56
Ultrastructural, biochemical, and functional characteristics of histamine-containing cells cloned from mouse bone marrow: tentative identification as mucosal mast cells. J Immunol (1983) 1.50
Isolation and characterization of heparin from human lung. J Clin Invest (1979) 1.46
Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation. J Immunol (1995) 1.42
C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol (1996) 1.37
Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol (2002) 1.37
Phagocytosis of mast cell granules by cultured fibroblasts. J Immunol (1983) 1.34
Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp Hematol (2000) 1.34
Stem cell factor induces mast cell adhesion to fibronectin. J Immunol (1994) 1.28
A clinical, microbiological, and histopathologic study of trichostasis spinulosa. J Dermatol (1998) 1.27
The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol (1997) 1.27
Mast cell-T cell interactions. J Allergy Clin Immunol (1999) 1.26
Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma. J Immunol (2000) 1.23
Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest (1981) 1.23
Evaluation of immediate adverse reactions to foods in adult patients. II. A detailed analysis of reaction patterns during oral food challenge. J Allergy Clin Immunol (1985) 1.23
NIH conference. Asthma. Ann Intern Med (1994) 1.22
Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells. Blood (2001) 1.21
Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol (1988) 1.21
Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem J (1987) 1.19
Identification of tropomyosin as the major shrimp allergen and characterization of its IgE-binding epitopes. J Immunol (1993) 1.18
Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Blood (1994) 1.17
Food allergies. JAMA (1992) 1.16
An avidin--biotin microELISA for rapid measurement of total and allergen-specific human IgE. J Immunol Methods (1983) 1.15
Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma. J Allergy Clin Immunol (2001) 1.12
Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol (2000) 1.12
Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum (1986) 1.10
Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology (1988) 1.09
Kit signal transduction. Hematol Oncol Clin North Am (2000) 1.07
Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur J Immunol (2000) 1.06
Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol (1997) 1.05
Polydispersity of rat mast cell heparin. Implications for proteoglycan assembly. J Biol Chem (1980) 1.05
Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer (1998) 1.05
Human eosinophil adherence to serum-treated sepharose: granule-associated enzyme release and requirement for activation of the alternative complement pathway. J Immunol (1977) 1.05
Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum (1987) 1.04
Mouse heparin proteoglycan. Synthesis by mast cell-fibroblast monolayers during lymphocyte-dependent mast cell proliferation. J Biol Chem (1982) 1.04
Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J Allergy Clin Immunol (1992) 1.04
Early expression of high-affinity receptor for immunoglobulin E (Fc epsilon RI) during differentiation of mouse mast cells and human basophils. J Clin Invest (1990) 1.03
IL-3-dependent growth of basophil-like cells and mastlike cells from human bone marrow. J Immunol (1989) 1.02
Mast cell heterogeneity: evidence and implications. J Clin Immunol (1984) 1.01
Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation. Clin Exp Allergy (2009) 1.00
Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol (1997) 1.00
Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med (1991) 1.00
TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol (2005) 1.00
IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J Immunol (1992) 1.00
Degradation of the heparin matrix of mast cell granules by cultured fibroblasts. J Immunol (1983) 0.99
An association between susceptibility to experimental autoimmune uveitis and choroidal mast cell numbers. J Immunol (1984) 0.99
Frequency and characterization of antigen-specific IL-4- and IL-13- producing basophils and T cells in peripheral blood of healthy and asthmatic subjects. J Allergy Clin Immunol (1999) 0.98
Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J Clin Invest (1997) 0.98
Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol (1998) 0.98
Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clin Exp Allergy (2011) 0.98
Interactions between mast cells, fibroblasts and connective tissue components. Int Arch Allergy Appl Immunol (1985) 0.97
Pediatric mastocytosis. J Invest Dermatol (1991) 0.97
Regulation of adhesion of mouse bone marrow-derived mast cells to laminin. J Immunol (1990) 0.97
The Kit-activating mutation D816V enhances stem cell factor--dependent chemotaxis. Blood (2001) 0.97
Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. Blood (1999) 0.96
Identification of an amino acid sequence in the laminin A chain mediating mast cell attachment and spreading. Immunology (1991) 0.96
Laminin promotes mast cell attachment. J Immunol (1989) 0.96
Arthritis and mast cell activation. J Allergy Clin Immunol (1990) 0.96
Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol (1994) 0.95
Paediatric mastocytosis. Arch Dis Child (2002) 0.95
IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur J Immunol (2001) 0.95
A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis. Bone Marrow Transplant (2006) 0.95
Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. New Biol (1992) 0.95
Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial. Am J Med (1985) 0.94
Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation. J Immunol (1994) 0.94
Coexistence of classic lichen planus and lichen planus pigmentosus-inversus: resistant to both tacrolimus and clobetasol propionate ointments. J Eur Acad Dermatol Venereol (2008) 0.94
The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis. Int Arch Allergy Immunol (1995) 0.94
Inhibition of IgE-mediated mast cell degranulation by sulphasalazine. Eur J Pharmacol (1985) 0.94
Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. J Clin Invest (1991) 0.93
Gastrointestinal mast cells in health and disease. Part II. J Pediatr (1983) 0.93
Gastrointestinal mast cells in health and disease. Part I. J Pediatr (1983) 0.93
Identification of a polymorphism in the transmembrane domain of the protooncogene c-kit in healthy subjects. Exp Clin Immunogenet (1996) 0.92
Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A. J Immunol (1997) 0.92
Mast cell adhesion to fibronectin. Immunology (1991) 0.92
Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. Immunology (2000) 0.92
On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts. Eur J Clin Invest (2004) 0.92
Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases. Hepatology (1995) 0.92
Immortalization of mouse bone marrow-derived mast cells with Ad12-SV40 virus. Int Arch Allergy Immunol (1993) 0.92